Journal of Commercial Biotechnology

Editorial: Are clinical trial authorisations truly being harmonised?
pp. 5-8(4)
Author: Horton, Linda R

Bioentrepreneurship in Japan: Institutional transformation and the growth of bioventures
pp. 9-37(29)
Author: Lynskey, Michael J

Changes to the European Union pharmaceutical legislation: Implications of the `Pharma Review' for biotechnology companies
pp. 38-43(6)
Author: Liikanen, Erkki

A brave new Europe with the introduction of the EU Clinical Trials Directive: Impact upon the pharma industry and academic research with special emphasis on pharmacovigilance
pp. 44-53(10)
Author: Ladds, Graeme

Interference basics
pp. 54-62(9)
Authors: Kowalski, Thomas J; Lawrence, William F; Megerditchian, Samuel H

Where will industry go to for its high-calibre staff?
pp. 63-71(9)
Authors: Kermani, Faiz; Gittins, Rebecca

Cross-border transactions: A roadmap for commercial arrangements between North American and European companies
pp. 72-79(8)
Authors: Fersko, Raymond S; Merabet, Hind; Cordioli, Valentina

Biotech blockbuster forecasts to 2008
pp. 80-86(7)
Authors: Pavlou, Alex K; Belsey, Mark

Regulatory data protection for medicines
pp. 87-96(10)
Authors: Wilkinson, John; Dorey, Frederick J

Financial accounts reports
pp. 97-99(3)
Author: Aaronson, Colin